Astrazeneca Plc Adr Stock Widgets and Gadgets
AZN Stock | USD 67.75 0.51 0.75% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- AZN AstraZeneca PLC ADR
- Latest FTSE 100 treads water despite takeover news boosting two stocks
- AZN 67.75 -0.51
- Low 67.68
- High 68.35
- Volume 3.6 M
- Alpha -0.0559
- Beta 0.88
- Return On Equity 0.16
- Return On Asset 0.066
- Profit Margin 0.13 %
- Operating Margin 0.17 %
- Current Valuation 233.04 B
- Shares Outstanding 3.1 B
- Shares Owned By Institutions 16.79 %
- Number Of Shares Shorted 10.48 M
- Price To Earning 103.39 X
- Price To Book 5.41 X
- Price To Sales 4.60 X
- Revenue 45.81 B
- Gross Profit 35.73 B
- EBITDA 13.91 B
- Net Income 6.9 B
- Cash And Equivalents 4.52 B
- Cash Per Share 1.46 X
- Total Debt 28.62 B
- Debt To Equity 0.89 %
- Current Ratio 0.81 X
- Book Value Per Share 25.25 X
- Cash Flow From Operations 10.35 B
- Short Ratio 1.87 X
- Earnings Per Share 1.90 X
- Price To Earnings To Growth 0.88 X
- Target Price 81.83
- Number Of Employees 89.9 K
- Beta 0.17
- Market Capitalization 210.7 B
- Total Asset 101.12 B
- Retained Earnings 1.5 B
- Working Capital (5.49 B)
- Current Asset 16.01 B
- Current Liabilities 14.87 B
- Z Score 5.28
- Annual Yield 0.02 %
- Five Year Return 2.99 %
- Net Asset 101.12 B
- Last Dividend Paid 2.9
- Accumulation Distribution 35455.63
- Daily Balance Of Power (0.76)
- Rate Of Daily Change 0.99
- Day Median Price 68.02
- Day Typical Price 67.93
- Price Action Indicator (0.52)
- Period Momentum Indicator (0.51)
Market Snapshot Widget Example
DAX Index Germany | 18,492 0.08 | |
Taiwan Weighted Taiwan | 20,147 0.27 | |
PSI 20 Stock Portugal | 6,280 0.06 | |
CROBEX Croatia | 2,835 0.28 | |
Budapest SE Hungary | 65,385 0.86 | |
IDX 30 Jakarta Indonesia | 501.16 0.43 | |
ISEQ 20 Price Ireland | 1,637 0.3 | |
NYSE Comp USA | 18,313 0.31 | |
Tel Aviv 35 Israel | 2,009 0.52 | |
Coreshares Index Tracker South Afric | 1,052 0.57 | |
IPC MEXICO Mexico | 57,369 0.28 | |
KL Technology Malaysia | 64.31 0.42 | |
IBEX 35 Index Spain | 11,075 0.33 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,536 0.35 | |
SPASX Dividend Opportunities Australia | 1,686 1.06 | |
HNX 30 Vietnam | 535.69 0.53 | |
Bucharest BET-NG Romania | 1,210 0.34 | |
AMS Small Cap Netherlands | 1,223 0.45 | |
Oslo Exchange Mutual Norway | 1,280 0.47 | |
BEL Small Belgium | 9,273 0.52 | |
RTSI Index Russia | 1,126 0.19 | |
Basic Materials Brazil | 6,016 0.18 | |
Swiss Leader Price Switzerland | 1,924 0.25 | |
Athens General Comp Greece | 1,422 0.34 | |
Stock Exchange Of Thailand | 1,370 0.76 | |
PX Prague Stock Czech Repub | 1,513 1.55 | |
THE PHILIPPINE STOCK Philippines | 6,904 0.08 | |
WIG 30 Poland | 3,022 1.59 | |
BIST Electricity Turkey | 544.86 1.57 |
Investing Ideas
In addition to having AstraZeneca PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare AstraZeneca PLC
Compare AstraZeneca PLC To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.059 | Dividend Share 2.9 | Earnings Share 1.9 | Revenue Per Share 2.4547 | Quarterly Revenue Growth 0.073 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.